Tirzeptade lyophilified high 99% pepptide tr 10mg 15mg 20mg

Tirzeptaitide wani labari ne na glucose / gluctagon-kamar peptide 1 (glp-1) agjunist na ci gaba da motsa jiki a cikin manya tare da nau'in ciwon sukari 2 da kuma a ƙarƙashin bincike don amfani a ciki Gudanar da mai nauyi na zamani, manyan abubuwan da suka faru na zuciya da kuma gudanar da wasu yanayi, gami da gazawar zuciya da kuma kiba da ba na cirrhotic da ba na cirewa ba. Lokaci na 3 ya wuce shirin gwaji na gwaji na 1-5 don tantance Tirzeptaptide, a duk faɗin munanan mutane da ke da nau'in ciwon sukari 2. Amfani da Tirzepata a cikin karatun asibiti yana da alaƙa da ragamar ragin glycated hemoglobin (-1.87) da nauyin jiki (-6.2 zuwa -12 mol) da ragin jiki (-6.2 zuwa -12.9) hade da hadarin zuciya mai hadarin zuciya kamar hawan jini, bayanin viscorcici da kewaya m triglycerides. An yarda da Tirzepatitide sosai, tare da ƙarancin haɗarin hypoglycaemia lokacin da aka yi amfani da insulin ko insulin asirce kuma ya nuna a gaba ɗaya bayanin kula mai rikice-rikice zuwa aji na Glp-1. Dangane da cewa, hujja daga wadannan fitokin na asibiti sun nuna cewa Tirzeptaide yana ba da sabuwar dama don ingancin rage hemoglobin da manya a cikin manya tare da nau'in ciwon sukari 2.